[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Safety assessment and pharmaceutical effects of astaxanthin: An overview

Madan Kumar, P. and Naveen, J. and Janani, R. and Baskaran, V. (2021) Safety assessment and pharmaceutical effects of astaxanthin: An overview. In: Global Perspectives on Astaxanthin. Academic press, pp. 569-591. ISBN 978-0-12-823304-7

[thumbnail of Safety assessment and pharmaceutical effects of astaxanthin - An overview.pdf] PDF
Safety assessment and pharmaceutical effects of astaxanthin - An overview.pdf - Published Version
Restricted to Registered users only

Download (218kB)

Abstract

This chapter describes the current astaxanthin (ASX) research development focusing on its safety assessment and pharmaceutical effects. ASX (3,3′-dihydroxy-β and β′-carotene-4,4′-dione) is a naturally occurring carotenoid found mainly in Haematococcus pluvialis (the green microalga) and marine organisms such as microalgae, salmon, and crustaceans. ASX, a nonpolar carotenoid with conjugated double bonds, shown to exhibit greater antioxidant function. Additionally, ASX has well-documented antidiabetic, antiinflammatory, anticancer, antiaging, immunomodulatory, heart protective, and liver protective effects. Significant scientific evidences, including human and animal data, suggest natural ASX as a safe nutrient for food and pharmaceutical application with no side effects. Altogether, natural ASX has gained high prominence in current research making it an attractive and economically potent molecule in the nutraceutical industry.

Item Type: Book Section
Uncontrolled Keywords: Safety assessment, Carotenoids, astaxanthin
Subjects: 500 Natural Sciences and Mathematics > 04 Chemistry and Allied Sciences > 14 Carotenoid Chemistry
600 Technology > 08 Food technology > 13 Quality control > 02 Safety
Divisions: Dept. of Biochemistry
Depositing User: Somashekar K S
Date Deposited: 21 Nov 2025 09:08
Last Modified: 21 Nov 2025 09:08
URI: http://ir.cftri.res.in/id/eprint/20114

Actions (login required)

View Item View Item